Repatha results show reduction for Type 2 diabetes patients

You are here: Home > Central Coast Health Watch > Current Article

Repatha study shows cholesterol reduction for Type 2 diabetes patients

By Staff Report / Monday, June 25th, 2018 / Comments Off on Repatha study shows cholesterol reduction for Type 2 diabetes patients

Amgen announced the release of new data from a phase 3 study June 23 that showed its cholesterol drug Repatha reduced two key types of cholesterol by more than 50 percent in patients with Type 2 diabetes. Presented at the American Diabetes Association annual meeting, the study – dubbed Banting by the Thousand Oaks biotech…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.